Presentation Information
[A1424-2pm-01]Novel Antibody based Drug Development Enabled by AJICAP® Site-Specific Conjugation Technology
○Haru Marumo1, Tomohiro Fujii1, Tomohiro Watanebe1, Yusuke Iwai1, Atsushi Tsuruta1, Natsuki Shikida1, Kazutaka Shimbo1, Junichi Terasawa1, Rika Takasugi1, Tsubasa Aoki1 (1. AJINOMOTO CO., INC.)
Keywords:
site-specific modification,hydrophilic linker,oligonucleotide conjugate
